2018
Dr. Kristen Bubb
University of Sydney
Is substance P / neurokinin 1 signalling a promising target for treatment of pulmonary hypertension?
Dr. Anna Hudson
Neuroscience Research Australia
Understanding impaired neural control of the respiratory muscles in chronic obstructive pulmonary disease
Dr. Ronan Kapetanovic
University of Queensland
Enhancing antimicrobial pathways in innate immune cells to combat bacterial infections in the lung
Dr. Pawan Sharma
University of Technology Sydney
Impact of maternal vaping on lung infection and asthma development in the offspring
Dr. Shannon Simpson
Telethon Kids Institute
Challenging the dogma: Active lung disease long after preterm birth?
Dr. Sarvesh Kumar Soni
RMIT University
Inhaled therapeutics for the treatment of childhood Tuberculosis with a next generation nebulisation platform
Dr. Miranda Ween
Royal Adelaide Hospital
Testing the effects of temperature and wattage of the newest generation of E-cigarettes on lung cells
2019
Dr Adam Collison
University of Newcastle
The Immunological profile of the early development of asthma
Dr Luke Knibbs
University of Queensland
New paradigms for infection control in people with Cystic Fibrosis
Dr Saleela Ruwanpura
Hudson Institute of Medical Research
ADAM17 as a novel target for therapeutic intervention in Chronic Obstructive Pulmonary Disease (COPD)
Dr Sukhwinder Sohal
University of Tasmania
Airway macrophage phenotypic switch drives epithelial-mesenchymal transition (EMT) in smokers and COPD: implications for early therapy
Dr Kate Sutherland
University of Sydney
Impact of Oral Appliance Treatment for Sleep-Disordered Breathing on Cardiovascular Health Measures
Dr Shafagh Waters
University of New South Wales
Personalised Lab Grown Mini-Lungs to Predict Effect of Therapies in Patients with Cystic Fibrosis
2020
Dr Catherine Burke
University of Technology Sydney
Manipulating Respiratory Microbiomes for the Reduction of Virally Induced Exacerbations in Chronic Obstructive Pulmonary Disease
Dr Kamal Dua
University of Technology Sydney
Identification and development of potential novel therapeutic interventions for influenza infection in asthma
Dr Alice McGovern
University of Melbourne
Does chronic lung disease alter brain inhibitory control processing?
Dr Christian Osadnik
Monash University
Improving Rehabilitation After COPD Exacerbations (iRACE)
Dr Eugene Roscioli
Royal Adelaide Hospital
Towards next generation antibiotics: addressing an off-target effect of azithromycin in chronic obstructive pulmonary disease (COPD)
Dr Ran Wang
University of Queensland
Harnessing the therapeutic potential of IL-22 in resolving bronchiolitis and asthma